Meeting Banner
Abstract #1784

Unraveling the Role of Choline Kinase in Cancer

Noriko Mori1, Flonne Wildes1, Kristine Glunde1, 2, Catherine Hudson3, Zaver M. Bhujwalla1, 2

1JHU ICMIC Program, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; 2The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine; 3Vertex Pharmaceuticals (Europe) Ltd, Abingdon, Abingdon, Oxfordshire, United Kingdom

High choline kinase (Chk) expression and increased phosphocholine (PC) levels are frequently observed in aggressive cancers. Unraveling the role of Chk and PC will provide new insights in the malignant phenotype and lead to the development of treatments targeting this enzyme and choline metabolism. We previously observed that downregulating Chk expression with siRNA resulted in a significant reduction of PC and proliferation in breast cancer cells. Here we have found that a potent inhibitor of Chk activity reduced PC without altering cell proliferation, pointing to the importance of the enzyme, but not necessarily its activity, in breast cancer cell survival.

Abstract PDF

Keywords

activity antibody approximately assay assays aver binding biting breast cancer cell cells choline closely collected compound comprehensive conditions consistent control culture custom days detected deviation done dose dual enzyme error essential established examined expanded expression extracts form free fresh fully function grow hours human inhibition inhibitor internal invasion involves ions johns kingdom lipid loaded loading made malignant manufacturer markedly media medicine medium metastatic monoclonal owed page potential previously program proliferation protein quantified radiological radiology reaction reduced reduces reducing reduction related relaxed resolved school significantly site spectra starting steep suggest supplemented support treated treatment untreated vehicle vertex viability water widely